Purchase Order 75F40125P00090

Award Date 6/11/25
Potential Completion Date 6/10/26
Potential Value $4.1M
Awardee
Agisol LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a sole source 8(a) contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, a Minority Owned, Economically Disadvantaged, Women-Owned Small Business (EDWOSB) located in the DC Metro area. The contract, valued at $899,910.69, is for business process user support services to the Center for Drug Evaluation and Research (CDER) at the FDA. Agisol LLC has received over $15 million in prime federal contracts from HHS FDA, including...
This is a $2,469,135.04 definitive, firm-fixed-price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Agisol LLC, an 8(a) certified Small Disadvantaged Business. The contract is for facilitation and coordination support services for IT initiatives, including regulatory review and production support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), support for the Center for Drug Evaluation and Research (CDER),...
This is a federal contract award to Agisol LLC, a small business and SBA-certified 8(a) Program participant, by the U.S. Food and Drug Administration (FDA). The contract is valued at $2,538,816.41 and provides office support services for the FDA's Office of Clinical Policy. The contract is a delivery order issued under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), a $50 billion multiple-award contract vehicle for IT services and solutions managed by the General Services...
This is a labor-hour award made by the U.S. Food and Drug Administration (FDA) to Agisol LLC, an 8(a) certified small disadvantaged business, to provide regulatory review of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS) production support services for the Center for Drug Evaluation and Research (CDER). The contract, valued at $4,499,636.43, runs from the award date of February 4, 2024 through December 17, 2025. Agisol LLC has extensive experience supporting the FDA's...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a one-year, $1.5 million firm fixed price delivery order contract to Agisol LLC. The contract is for CDER Regulatory Review Systems and Data Support under the Multiple Award Schedule contract vehicle. As the prime, Agisol will provide information technology services and solutions to support HHS FDA's Center for Drug Evaluation and Research programs. No subcontractors or set aside designations were...
The Department of Health and Human Services Food and Drug Administration awarded a $3.8 million definitive contract to Agisol LLC of Silver Spring, Maryland. The contract is for the DOCUMENT ARCHIVING, REPORTING, AND REGULATORY TRACKING SYSTEM and has a period of performance from January 21, 2022 to January 17, 2024. The pricing structure is firm fixed price. The contract was set aside for 8(a) Sole Source small businesses. Agisol LLC will provide document archiving, reporting, and regulatory...
The Food and Drug Administration (FDA) awarded an $4,494,448.70 firm-fixed-price delivery order contract to Agilistek LLC, an 8(a) small disadvantaged business, to provide development, enhancement, and maintenance services for the agency's Foreign Inspection Planning and Scheduling System (FIPSS). This contract is a task order issued under Agilistek's prime 8(a) STARS III Governmentwide Acquisition Contract (GWAC), a $50 billion multiple-award vehicle managed by the General Services...
This is a $4,425,947.90 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to A1Fedimpact, LLC, a small business prime contractor, to provide Enterprise Performance Life Cycle (EPLC) and intake support services. The contract has a period of performance that runs through July 12, 2026 and does not have a set-aside designation. A1Fedimpact, LLC is a certified 8(a) joint venture that holds multiple socioeconomic certifications, including minority-owned,...
Agilistek LLC, a minority-owned small business certified as an 8(a) Small Disadvantaged Business, was awarded a $2,808,691.95 sole source delivery order under the 8(a) STARS III Governmentwide Acquisition Contract (GWAC) to provide Phase 4 development, enhancement, and maintenance support for the Food and Drug Administration's (FDA) Foreign Inspection Planning and Scheduling System (FIPSS) from September 2023 to September 2024. This 8(a) set-aside contract will be executed using labor hour...
This is a $30,676.16 firm fixed-price purchase order awarded by the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC), a civilian agency, to Agilistek LLC, a minority-owned small disadvantaged business. The contract is for the payment of a protest claim and associated attorneys' fees and expenses related to the CIO-SP4 solicitation. Agilistek is a key contractor for the Food and Drug Administration (FDA), providing IT services and solutions,...

This is a $4,075,658.29 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Agisol LLC, a small business and Economically Disadvantaged Women-Owned Small Business (EDWOSB) certified in the SBA 8(a) program. The contract is for operations and maintenance services for the CDERONE (Center for Drug Evaluation and Research Operations) system, which supports regulatory review and evaluation processes for drugs. Agisol LLC has a history of providing IT services and solutions to the FDA, including support for the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), CDER business processes, and other initiatives related to drug evaluation and research. The contract does not have a set-aside designation. Agisol LLC holds an 8(a) STARS III Government-Wide Acquisition Contract (GWAC) with the General Services Administration (GSA), which has enabled the company to receive additional task orders from the FDA for regulatory review and process support services.

Generated 6/13/25, 10:04 AM